Literature DB >> 12709025

Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison.

Claire L Harris1, S Melanie Hanna, Masashi Mizuno, Dewi S Holt, Kevin J Marchbank, B Paul Morgan.   

Abstract

CD59, the sole membrane regulator of the membrane attack complex of complement, is broadly and abundantly expressed in man and other mammals. In mouse, CD59 is encoded by two homologous genes. The expression patterns and functional roles of the proteins encoded by these genes, mCD59a and mCD59b, have not been well characterized. Here we describe the generation of monoclonal and polyclonal antibodies detecting specifically mCD59a and mCD59b. These reagents have been used to study function and to ascertain the cell and tissue distributions of mCD59a and mCD59b. mCD59a was broadly distributed on endothelia, erythrocytes, platelets, and on numerous other cell types in organs, a distribution pattern resembling that of CD59 in other species. In marked contrast, expression of mCD59b was restricted to germ cell elements in the testis and mature spermatozoa. Both mCD59a and CD59b inhibited human and rodent complement with similar efficiency. These findings demonstrate that the broadly distributed mCD59a is the key regulator of the terminal complement pathway in mice whereas CD59b, expressed only in testis and on sperm, probably plays other roles in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709025      PMCID: PMC1782952          DOI: 10.1046/j.1365-2567.2003.01628.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria.

Authors:  D S Holt; M Botto; A E Bygrave; S M Hanna; M J Walport; B P Morgan
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

2.  Molecular cloning and functional characterization of the pig analogue of CD59: relevance to xenotransplantation.

Authors:  S J Hinchliffe; N K Rushmere; S M Hanna; B P Morgan
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

3.  Genomic structure, functional comparison, and tissue distribution of mouse Cd59a and Cd59b.

Authors:  X Qin; T Miwa; H Aktas; M Gao; C Lee; Y M Qian; C C Morton; A Shahsafaei; W C Song; J A Halperin
Journal:  Mamm Genome       Date:  2001-08       Impact factor: 2.957

4.  Efficient generation of monoclonal antibodies against surface-expressed proteins by hyperexpression in rodent cells.

Authors:  O B Spiller; C L Harris; B P Morgan
Journal:  J Immunol Methods       Date:  1999-04-22       Impact factor: 2.303

5.  Tissue distribution of the rat analogue of decay-accelerating factor.

Authors:  O B Spiller; S M Hanna; B P Morgan
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

6.  The glycosylation of the complement regulatory protein, human erythrocyte CD59.

Authors:  P M Rudd; B P Morgan; M R Wormald; D J Harvey; C W van den Berg; S J Davis; M A Ferguson; R A Dwek
Journal:  J Biol Chem       Date:  1997-03-14       Impact factor: 5.157

7.  Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities.

Authors:  C L Harris; O B Spiller; B P Morgan
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

8.  Genomic structure and chromosome location of the gene encoding mouse CD59.

Authors:  D S Holt; M B Powell; N K Rushmere; B P Morgan
Journal:  Cytogenet Cell Genet       Date:  2000

9.  Identification and functional characterization of a new gene encoding the mouse terminal complement inhibitor CD59.

Authors:  Y M Qian; X Qin; T Miwa; X Sun; J A Halperin; W C Song
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

10.  The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity.

Authors:  C W van den Berg; R A Harrison; B P Morgan
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

View more
  17 in total

1.  Cutting edge: murine CD59a modulates antiviral CD4+ T cell activity in a complement-independent manner.

Authors:  M Paula Longhi; Baalasubramanian Sivasankar; Nader Omidvar; B Paul Morgan; Awen Gallimore
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

Review 2.  Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2017-03-24       Impact factor: 2.801

3.  Recombinant membrane-targeted form of CD59 inhibits the growth of choroidal neovascular complex in mice.

Authors:  Nalini S Bora; Purushottam Jha; Valeriy V Lyzogubov; Sankaranarayanan Kaliappan; Juan Liu; Ruslana G Tytarenko; Deborah A Fraser; B Paul Morgan; Puran S Bora
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

4.  IgG subclasses and complement pathway in segmental and global membranous nephropathy.

Authors:  Yoshie Segawa; Satoshi Hisano; Misao Matsushita; Teizo Fujita; Shinichi Hirose; Morishige Takeshita; Hiroshi Iwasaki
Journal:  Pediatr Nephrol       Date:  2010-02-12       Impact factor: 3.714

5.  Epididymal C4b-binding protein is processed and degraded during transit through the duct and is not essential for fertility.

Authors:  Mayumi I Nonaka; Eva Zsigmond; Akihiko Kudo; Hayato Kawakami; Kaoru Yoshida; Manabu Yoshida; Natsuko Kawano; Kenji Miyado; Masaru Nonaka; Rick A Wetsel
Journal:  Immunobiology       Date:  2014-11-11       Impact factor: 3.144

6.  The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury.

Authors:  Fei Qiao; Carl Atkinson; Mark S Kindy; Anandakumar Shunmugavel; B Paul Morgan; Hongbin Song; Stephen Tomlinson
Journal:  Am J Pathol       Date:  2010-10-15       Impact factor: 4.307

7.  Mouse Cd59b but not Cd59a is upregulated to protect cells from complement attack in response to inflammatory stimulation.

Authors:  J Chen; Y Du; P Ding; X Zhang; L Zhang; N Wang; W Hu
Journal:  Genes Immun       Date:  2015-07-23       Impact factor: 2.676

8.  An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice.

Authors:  Marieta M Ruseva; Valeria Ramaglia; B Paul Morgan; Claire L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

9.  Deficiency of decay-accelerating factor and complement receptor 1-related gene/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIg.

Authors:  David D Kim; Takashi Miwa; Yuko Kimura; Reto A Schwendener; Menno van Lookeren Campagne; Wen-Chao Song
Journal:  Blood       Date:  2008-06-04       Impact factor: 22.113

10.  Absence of CD59 exacerbates systemic autoimmunity in MRL/lpr mice.

Authors:  Takashi Miwa; Lin Zhou; Michael A Maldonado; Michael P Madaio; Robert A Eisenberg; Wen-Chao Song
Journal:  J Immunol       Date:  2012-10-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.